Cargando…
Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues”
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598754/ https://www.ncbi.nlm.nih.gov/pubmed/33130185 http://dx.doi.org/10.1016/j.jhep.2020.10.020 |
_version_ | 1783602703984754688 |
---|---|
author | Ji, Dong Cheng, Gregory Lau, George |
author_facet | Ji, Dong Cheng, Gregory Lau, George |
author_sort | Ji, Dong |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7598754 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | European Association for the Study of the Liver. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75987542020-11-02 Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues” Ji, Dong Cheng, Gregory Lau, George J Hepatol Letter to the Editor European Association for the Study of the Liver. Published by Elsevier B.V. 2021-02 2020-10-29 /pmc/articles/PMC7598754/ /pubmed/33130185 http://dx.doi.org/10.1016/j.jhep.2020.10.020 Text en © 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Ji, Dong Cheng, Gregory Lau, George Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues” |
title | Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues” |
title_full | Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues” |
title_fullStr | Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues” |
title_full_unstemmed | Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues” |
title_short | Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues” |
title_sort | reply to: “nafld is a predictor of liver injury in covid-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – the debate continues” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598754/ https://www.ncbi.nlm.nih.gov/pubmed/33130185 http://dx.doi.org/10.1016/j.jhep.2020.10.020 |
work_keys_str_mv | AT jidong replytonafldisapredictorofliverinjuryincovid19hospitalizedpatientsbutnotofmortalitydiseaseseverityonthepresentationorprogressionthedebatecontinues AT chenggregory replytonafldisapredictorofliverinjuryincovid19hospitalizedpatientsbutnotofmortalitydiseaseseverityonthepresentationorprogressionthedebatecontinues AT laugeorge replytonafldisapredictorofliverinjuryincovid19hospitalizedpatientsbutnotofmortalitydiseaseseverityonthepresentationorprogressionthedebatecontinues |